Valsartan Tablet
Product Images NDC 43547-369

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Valsartan (NDC 43547-369). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Solco Healthcare Us, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

C:\users\ra\desktop\untitled.jpg (Ee945890 Figure 01)

FDA Label Image

C:\users\ra\desktop\untitled.jpg (Ee945890 Figure 02)

This appears to be a table showing patient subgroups and percentages related to a comparison study between Valsartan and Captopril. The subgroups include age, gender, ethnicity, and country of origin. There is also mention of the usage of beta-blockers during the study. The percentages seem to show a comparison between the two medications, with indications of which medication is in favor.*

FDA Label Image

C:\users\ra\pictures\1.jpg (Ee945890 Figure 03)

FDA Label Image

C:\users\ra\pictures\2.jpg (Ee945890 Figure 04)

FDA Label Image

C:\users\ra\pictures\3.jpg (Ee945890 Figure 05)

FDA Label Image

C:\users\ra\pictures\4.png (Ee945890 Figure 06)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.